1. ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression
   Fátima Ferragut et al, 2021, Cytokine & Growth Factor Reviews CrossRef
2. Multifaceted effects of soluble human CD6 in experimental cancer models
   Inês T Simões et al, 2020, Journal for ImmunoTherapy of Cancer CrossRef
3. Linoleic acid induces migration and invasion through FFAR4- and PI3K-/Akt-dependent pathway in MDA-MB-231 breast cancer cells
   Nathalia Serna-Marquez et al, 2017, Medical Oncology CrossRef
4. Clinical significance of CD166 and HER-2 in different types of gastric cancer
   Leila Moradi et al, 2023, Clinical and Translational Oncology CrossRef
5. Identification of breast cancer recurrence risk factors based on functional pathways in tumor and normal tissues
   Xiujie Chen et al, 2017, Oncotarget CrossRef
6. Up-Regulation of miR-9 Target CBX7 to Regulate Invasion Ability of Bladder Transitional Cell Carcinoma
   Xiaojie Tong, 2015, Medical Science Monitor CrossRef
7. A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker
   Meng Xiao et al, 2016, Expert Review of Molecular Diagnostics CrossRef
8. Stromal Expression of Activated Leukocyte Cell Adhesion Molecule Promotes Lung Tumor Growth and Metastasis
   Ann-Helen Willrodt et al, 2017, The American Journal of Pathology CrossRef
9. Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1
   Myoung-Hee Kang et al, 2017, Oncotarget CrossRef
10. Lesser-Known Molecules in Ovarian Carcinogenesis
    Ludmila Lozneanu et al, 2015, BioMed Research International CrossRef
11. Activated Leukocyte Cell Adhesion Molecule Stimulates the T-Cell Response in Allergic Asthma
    Mi Na Kim et al, 2018, American Journal of Respiratory and Critical Care Medicine CrossRef
12. Integrated bioinformatics analysis of miRNA expression in Ewing sarcoma and potential regulatory effects of miR-21 via targeting ALCAM/CD166
    Yuzhe Liu et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
13. Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination
    Andrew J. Sanders et al, 2019, Oncotarget CrossRef
14. MicroRNA‑9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A‑2
    Fei Xue et al, 2017, Oncology Letters CrossRef
15. Predicting Value of ALCAM as a Target Gene of microRNA-483-5p in Patients with Early Recurrence in Hepatocellular Carcinoma
    Xin-Yuan Lu et al, 2018, Frontiers in Pharmacology CrossRef
16. Gastric Cancer Cell-Derived Exosomes Can Regulate the Biological Functions of Mesenchymal Stem Cells by Inducing the Expression of Circular RNA circ_0004303
    Li Ba et al, 2021, Stem Cells and Development CrossRef
17. The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers
    Yiming Yang et al, 2021, Cancers CrossRef
18. CD166-mediated epidermal growth factor receptor phosphorylation promotes the growth of oral squamous cell carcinoma
    Guodong Jia et al, 2016, Oral Oncology CrossRef
19. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?
    Kayhan Erturk et al, 2016, Biomedicine & Pharmacotherapy CrossRef
20. Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells
    Wei-Wei Zhang et al, 2016, Molecular Medicine Reports CrossRef